gabexate has been researched along with Embolism, Pulmonary in 2 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maeta, H | 1 |
| Imawaki, S | 1 |
| Shiraishi, Y | 1 |
| Tanaka, S | 1 |
| Shirakawa, Y | 1 |
| Komatsu, H | 1 |
| Miyazawa, T | 1 |
| Tanemori, N | 1 |
| Utsumi, T | 1 |
| Katayama, S | 1 |
| Furukawa, N | 1 |
2 other studies available for gabexate and Embolism, Pulmonary
| Article | Year |
|---|---|
[Clinical profile and treatment of acute pulmonary embolism].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Blood Gas Analysis; | 1992 |
[Balloon occlusion pulmonary angiography and anticoagulant-antithrombotic therapy in ARDS-associated pulmonary vascular thrombosis].
Topics: Adult; Aged; Gabexate; Guanidines; Heparin; Humans; Male; Middle Aged; Pulmonary Artery; Pulmonary E | 1991 |